These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 35455287)

  • 1. Correlations between Circulating and Tumor-Infiltrating CD4
    Al-Mterin MA; Murshed K; Elkord E
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between Circulating and Tumor-Infiltrating CD4
    Al-Mterin MA; Murshed K; Elkord E
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
    Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
    Front Immunol; 2019; 10():2936. PubMed ID: 31921188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of different immune checkpoints-expressing CD4
    Al-Mterin MA; Murshed K; Alsalman A; Abu-Dayeh A; Elkord E
    BMC Cancer; 2022 Jun; 22(1):601. PubMed ID: 35655158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral FoxP3
    Syed Khaja AS; Toor SM; El Salhat H; Ali BR; Elkord E
    Front Immunol; 2017; 8():619. PubMed ID: 28603527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8
    Alsalman A; Al-Mterin MA; Murshed K; Alloush F; Al-Shouli ST; Toor SM; Elkord E
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
    Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
    Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Maturation Status and Immune Phenotypes of Circulating Helios
    Zhang Y; Zhang J; Shi Y; Shen M; Lv H; Chen S; Feng Y; Chen H; Xu X; Yang T; Xu K
    Front Immunol; 2021; 12():628504. PubMed ID: 34054801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.
    Abd Al Samid M; Chaudhary B; Khaled YS; Ammori BJ; Elkord E
    Oncotarget; 2016 Mar; 7(12):14083-94. PubMed ID: 26885615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
    Müller M; Herrath J; Malmström V
    Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Regulatory T Cell Subsets and Their Expression of Helios and PD-1 in Patients with Hashimoto Thyroiditis.
    Hu Y; Zhang L; Chen H; Liu X; Zheng X; Shi H; Jiang L; Cui D
    Int J Endocrinol; 2019; 2019():5368473. PubMed ID: 31214258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4
    Saleh R; Toor SM; Khalaf S; Elkord E
    Vaccines (Basel); 2019 Oct; 7(4):. PubMed ID: 31614877
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcriptomic Profiling of Tumor-Infiltrating CD4
    Sasidharan Nair V; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Soofi ME; Ouararhni K; Alajez NM; Abu Nada M; Elkord E
    Vaccines (Basel); 2020 Feb; 8(1):. PubMed ID: 32041340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children.
    Khaitan A; Kravietz A; Mwamzuka M; Marshed F; Ilmet T; Said S; Ahmed A; Borkowsky W; Unutmaz D
    J Acquir Immune Defic Syndr; 2016 Aug; 72(5):474-84. PubMed ID: 27003495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting tumor-infiltrating CCR8
    Chen Q; Shen M; Yan M; Han X; Mu S; Li Y; Li L; Wang Y; Li S; Li T; Wang Y; Wang W; Wei Z; Hu C; Jin A
    J Transl Med; 2024 Jul; 22(1):709. PubMed ID: 39080766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP.
    Elkord E; Abd Al Samid M; Chaudhary B
    Oncotarget; 2015 Aug; 6(24):20026-36. PubMed ID: 26343373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foxp3
    Liu L; Zhang Q; Chen P; Guo N; Song A; Huang X; Xia W; Li L; Moog C; Wu H; Su B; Zhang T
    BMC Immunol; 2019 Oct; 20(1):38. PubMed ID: 31651258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
    Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
    J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro effect of pembrolizumab on different T regulatory cell subsets.
    Toor SM; Syed Khaja AS; Alkurd I; Elkord E
    Clin Exp Immunol; 2018 Feb; 191(2):189-197. PubMed ID: 28963773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.